347 related articles for article (PubMed ID: 6067476)
1. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol.
Levy B
J Pharmacol Exp Ther; 1967 Jun; 156(3):452-62. PubMed ID: 6067476
[No Abstract] [Full Text] [Related]
2. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine).
Levy B
J Pharmacol Exp Ther; 1966 Mar; 151(3):413-22. PubMed ID: 4380047
[No Abstract] [Full Text] [Related]
3. Dimethyl isopropylmethoxamine: a selective beta-receptor blocking agent.
Levy B
Br J Pharmacol Chemother; 1966 Aug; 27(2):277-85. PubMed ID: 5967366
[No Abstract] [Full Text] [Related]
4. Selective beta receptor blockade in rat smooth muscle.
Levy B
Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):418-27. PubMed ID: 6076589
[No Abstract] [Full Text] [Related]
5. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT; Gluckman MI
J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
[No Abstract] [Full Text] [Related]
6. The in vivo effects of beta adrenergic stimulation and blockade on the human uterus at term.
Mahon WA; Reid DW; Day RA
J Pharmacol Exp Ther; 1967 Apr; 156(1):178-85. PubMed ID: 6023594
[No Abstract] [Full Text] [Related]
7. [Local propranolol blocking of the beta-adrenergic receptors of the sinoatrial node during intravenous infusion of isoproterenol. Experimental research].
Mezzacapo B; Massaria E; Di Fabio D
Minerva Cardioangiol; 1969 Dec; 17(12):1074-9. PubMed ID: 4392066
[No Abstract] [Full Text] [Related]
8. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
Madan BR; Gupta RS; Jain BK
Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
[No Abstract] [Full Text] [Related]
9. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
Brunner H; Hedwall PR; Meier M
Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
[No Abstract] [Full Text] [Related]
10. The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agent.
Robson RD; Kaplan HR
J Pharmacol Exp Ther; 1970 Oct; 175(1):157-67. PubMed ID: 4394301
[No Abstract] [Full Text] [Related]
11. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
[No Abstract] [Full Text] [Related]
12. Adrenergic beta receptors and plasma free fatty acids.
Zsoter T; Tom H; Kraml M; Dvornik D
J Pharmacol Exp Ther; 1966 Jun; 152(3):425-31. PubMed ID: 4380725
[No Abstract] [Full Text] [Related]
13. [Action and mechanism of action of catecholamines and their derivatives].
Ariëns EJ
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):118-41. PubMed ID: 4385328
[No Abstract] [Full Text] [Related]
14. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
Ferrini R; Miragoli G; Croce G
Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
[No Abstract] [Full Text] [Related]
15. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
Levy JV
J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
[No Abstract] [Full Text] [Related]
16. Influence of propranolol and ICI 50,172 on the cardiovascular actions of catecholamines as modified by ergotamine.
Osswald W; Guimarães S; Garrett J
J Pharmacol Exp Ther; 1970 Aug; 174(2):315-22. PubMed ID: 5451366
[No Abstract] [Full Text] [Related]
17. Blockade of the biochemical correlates of contraction and relaxation in uterine and intestinal smooth muscle.
Brody TM; Diamond J
Ann N Y Acad Sci; 1967 Feb; 139(3):772-80. PubMed ID: 5232342
[No Abstract] [Full Text] [Related]
18. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
Giudicelli JF; Schmitt H; Boissier JR
J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
[No Abstract] [Full Text] [Related]
19. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
Tanenaka T; Tachikawa S
Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
[No Abstract] [Full Text] [Related]
20. Cardio-selective beta-blockade.
Barrett AM; Crowther AF; Dunlop D; Shanks RG; Smith LH
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):152-3. PubMed ID: 4232648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
